RESUMO
Plasma cells represent the final stage of B lymphocyte differentiation. Most plasma cells in secondary lymphoid tissues live for a few days, whereas those in the lamina propria of mucosa and in bone marrow live for several weeks. To investigate the regulation of human plasma cell survival, plasma cells were isolated from tonsils according to high CD38 and low CD20 expression. Tonsillar plasma cells express CD9, CD19, CD24, CD37, CD40, CD74, and HLA-DR, but not CD10, HLA-DQ, CD28, CD56, and Fas/CD95. Although plasma cells express intracytoplasmic Bcl-2, they undergo swift apoptosis in vitro and do not respond to CD40 triggering. Bone marrow fibroblasts and rheumatoid synoviocytes, however, prevented plasma cells from undergoing apoptosis in a contact-dependent fashion. These data indicate that fibroblasts may form a microenvironment favorable for plasma cell survival under normal and pathological conditions.
Assuntos
Apoptose , Medula Óssea/fisiologia , Fibroblastos/fisiologia , Tonsila Palatina/fisiologia , Plasmócitos/fisiologia , Antígenos CD , Artrite Reumatoide , Subpopulações de Linfócitos B , Células da Medula Óssea , Comunicação Celular , Sobrevivência Celular , Células Cultivadas , Dano ao DNA , Citometria de Fluxo , Antígenos HLA , Humanos , Imunoglobulina A/metabolismo , Imuno-Histoquímica , Mucosa , Tonsila Palatina/citologia , Tonsila Palatina/imunologia , Plasmócitos/imunologia , Plasmócitos/ultraestrutura , Proteínas Proto-Oncogênicas/isolamento & purificação , Proteínas Proto-Oncogênicas c-bcl-2 , Membrana Sinovial/citologia , Membrana Sinovial/fisiologiaRESUMO
After germinal center B cells undergo somatic mutation and antigen selection, they become either memory B cells or plasma cells, but the signal requirements that control entry into either pathway have been unclear. When purified human germinal center cells were cultured with interleukin-2, interleukin-10, and cells expressing CD40 ligand, cells with characteristics of memory B cells were generated. Removal of CD40 ligand from the system resulted in terminal differentiation of germinal center B cells into cells with the characteristics of plasma cells. These results indicate that CD40 ligand directs the differentiation of germinal center B cells toward memory B cells rather than toward plasma cells.
Assuntos
Subpopulações de Linfócitos B/imunologia , Diferenciação Celular/imunologia , Plasmócitos/imunologia , ADP-Ribosil Ciclase , ADP-Ribosil Ciclase 1 , Antígenos CD/análise , Antígenos CD20 , Antígenos de Diferenciação/análise , Antígenos de Diferenciação de Linfócitos B/análise , Ligante de CD40 , Divisão Celular/imunologia , Células Cultivadas , Humanos , Isotipos de Imunoglobulinas/análise , Memória Imunológica/imunologia , Imunofenotipagem , Linfonodos/citologia , Glicoproteínas de Membrana/imunologiaRESUMO
To understand the accumulation of plasma cells within RA synovium, the ability of rheumatoid synoviocytes to support the differentiation of B cells into plasma cells was explored. Tonsillar B lymphocytes cultured over confluent monolayers of synoviocytes, secreted threefold more Igs (mainly IgM) than B cells cultured directly on plastic well. More importantly, synoviocytes enhanced by 14-fold the production of Igs (mainly IgG) by B cells costimulated with Staphylococcus aureus Cowan (SAC) particles. IL-10 and, in a lower extent, IL-2 increased Ig secretion in cocultures, and their combination was synergistic. In the presence of SAC, IL-2, and IL-10, synoviocytes increased by 13-884-fold the production of IgG, which reached 0.19 ng/cell per day. RA as well as normal synoviocytes were more potent than other adherent cell lines to support terminal B cell differentiation. Synoviocyte activity involved both a support of B cell survival, and an induction of the terminal differentiation of B cells into mature plasma cells with typical morphology, high levels of intracytoplasmic Igs, and CD20- CD38high surface expression. The present observation should permit the identification of molecules involved in the maturation of B cells into plasma cells, and in their accumulation in rheumatoid synovium.
Assuntos
Artrite Reumatoide/imunologia , Linfócitos B/imunologia , Citocinas/farmacologia , Plasmócitos/imunologia , Membrana Sinovial/imunologia , Anticorpos Monoclonais , Formação de Anticorpos , Antígenos CD/análise , Antígenos CD/biossíntese , Antígenos CD20 , Antígenos de Diferenciação de Linfócitos B/biossíntese , Artrite Reumatoide/patologia , Linfócitos B/citologia , Linfócitos B/efeitos dos fármacos , Comunicação Celular/imunologia , Diferenciação Celular , Linhagem Celular , Células Cultivadas , Sinergismo Farmacológico , Citometria de Fluxo , Humanos , Técnicas Imunoenzimáticas , Imunoglobulina A/biossíntese , Imunoglobulina G/biossíntese , Imunoglobulina M/biossíntese , Interleucina-10/farmacologia , Interleucina-2/farmacologia , Cinética , Ativação Linfocitária , Plasmócitos/patologia , Proteínas Recombinantes/farmacologia , Membrana Sinovial/efeitos dos fármacos , Membrana Sinovial/patologia , Fatores de TempoRESUMO
In normal individuals, gammadelta T cells account for less than 6% of total peripheral T lymphocytes and mainly express T-cell receptor (TCR) Vdelta2-Vgamma9 chains. We have previously observed a dramatic expansion of gammadelta T cells in the peripheral blood of renal allograft recipients only when they developed cytomegalovirus (CMV) infection. This increase was long lasting (more than 1 year), was associated with an activation of gammadelta T cells, and concerned only Vdelta1 or Vdelta3 T-cell subpopulations. Analysis of gammadelta TCR junctional diversity revealed that CMV infection in these patients was accompanied by (a) a marked restriction of CDR3 size distribution in Vdelta3 and, to a lesser extent, in Vdelta1 chains; and (b) a selective expansion of Vdelta1 cells bearing recurrent junctional amino acid motifs. These features are highly suggestive of an in vivo antigen-driven selection of gammadelta T-cell subsets during the course of CMV infection. Furthermore, Vdelta1 and Vdelta3 T cells from CMV-infected kidney recipients were able to proliferate in vitro in the presence of free CMV or CMV-infected fibroblast lysates but not uninfected or other herpes virus-infected fibroblast lysates. This in vitro expansion was inhibited by anti-gammadelta TCR mAb's. These findings suggest that a population of gammadelta T cells might play an important role in the immune response of immunosuppressed patients to CMV infection.
Assuntos
Citomegalovirus/imunologia , Receptores de Antígenos de Linfócitos T gama-delta/metabolismo , Subpopulações de Linfócitos T/imunologia , Adolescente , Adulto , Sequência de Aminoácidos , Sequência de Bases , Criança , Infecções por Citomegalovirus/etiologia , Infecções por Citomegalovirus/imunologia , Primers do DNA/genética , Feminino , Humanos , Técnicas In Vitro , Transplante de Rim/efeitos adversos , Transplante de Rim/imunologia , Ativação Linfocitária , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Receptores de Antígenos de Linfócitos T gama-delta/genética , Fatores de TempoRESUMO
Leukemia Inhibitory Factor (LIF) has a wide variety of biological activities. It regulates the differentiation of embryonic stem cells, neural cells, osteoblasts, adipocytes, hepatocytes and kidney epithelial cells. It also triggers the proliferation of myoblasts, primordial germ cells and some endothelial cells. Many of these biological functions parallel those of interleukin-6, Oncostatin M, ciliary neurotrophic factor, interleukin-11 and cardiotrophin-1. These structurally related cytokines also share subunits of their receptors which could partially explain the redundancy in this system of soluble mediators. In vivo LIF proves important in regulating the inflammatory response by fine tuning of the delicate balance of at least four systems in the body, namely the immune, the hematopoietic, the nervous and the endocrine systems. Although we are far from its therapeutic applications, the fast increasing knowledge in this field may bring new insights for the understanding of the cytokine biology in general.
Assuntos
Inibidores do Crescimento/fisiologia , Interleucina-6 , Linfocinas/fisiologia , Animais , Humanos , Fator Inibidor de Leucemia , Subunidade alfa de Receptor de Fator Inibidor de Leucemia , Camundongos , Estrutura Molecular , Receptores de Citocinas/fisiologia , Receptores de OSM-LIFAssuntos
Receptores de Antígenos de Linfócitos T gama-delta/imunologia , Linfócitos T/virologia , Viroses/imunologia , Animais , Infecções por Citomegalovirus/imunologia , Humanos , Tolerância Imunológica/imunologia , Imunidade nas Mucosas/imunologia , Transplante de Rim/efeitos adversos , Linfócitos T/imunologia , Imunologia de Transplantes/imunologia , Transplante Homólogo , Vírus/imunologiaAssuntos
Infecções por Citomegalovirus/imunologia , Transplante de Rim/imunologia , Receptores de Antígenos de Linfócitos T gama-delta/imunologia , Subpopulações de Linfócitos T/imunologia , Quimioterapia Combinada , Feminino , Humanos , Imunossupressores/uso terapêutico , Contagem de Linfócitos , Masculino , Complicações Pós-Operatórias/imunologia , Estudos Retrospectivos , Uremia/imunologiaRESUMO
Rheumatoid synovitis is characterized by increased activation and proliferation of synoviocytes, which are an important source of cytokines. The role of Interleukin 4 (IL-4) and IL-10 on the production of mediators of inflammation by rheumatoid synoviocytes was studied herein. While IL-4 weakly affected the spontaneous PGE2 production, it strongly inhibited its production when cells were stimulated with IL-1 beta and TNF-alpha. IL-4 decreased by 60% to 80% the spontaneous and the IL-1 beta or TNF-alpha induced synthesis of GM-CSF. In contrast, IL-4 enhanced the spontaneous (2.6-fold), and to a lower extent (1.3-1.8-fold), the cytokine stimulated production of IL-6. This induction was not due to a passive release of pre-synthesized IL-6, since IL-4 increased the level of IL-6 mRNA expression induced by IL-1 beta. The D50 was 5 U/ml of IL-4 for both the stimulation of IL-6 synthesis and the inhibition of GM-CSF production. Kinetic studies of the action of IL-4 revealed a rapid and sustained inhibition of GM-CSF production, and a late increase of IL-6 secretion. By contrast, IL-10 had no effect on the production of either IL-6 or GM-CSF by synoviocytes. Thus, by inhibiting synoviocyte proliferation and inhibiting their secretion of PGE2 and GM-CSF, IL-4 displays on synoviocytes a series of biological effects which complements its anti-inflammatory properties on monocytes.
Assuntos
Artrite Reumatoide/fisiopatologia , Dinoprostona/biossíntese , Fator Estimulador de Colônias de Granulócitos e Macrófagos/biossíntese , Interleucina-10/farmacologia , Interleucina-4/farmacologia , Interleucina-6/biossíntese , Membrana Sinovial/fisiopatologia , Artrite Reumatoide/imunologia , Células Cultivadas , Expressão Gênica/efeitos dos fármacos , Humanos , Inflamação , Cinética , RNA Mensageiro/biossíntese , Proteínas Recombinantes/farmacologia , Membrana Sinovial/imunologia , Fatores de TempoRESUMO
Rheumatoid arthritis (RA) is associated with T- and B-cell dysfunction. Immunoglobulin (Ig) production is under the control of T cells and their derived cytokines such as interleukin 2 (IL-2) and IL-4. Herein we studied the regulation of the production of immunoglobulins and cytokines by peripheral blood mononuclear cells from RA patients and controls. In the controls, IL-4 inhibited Ig production in response to Staphylococcus aureus and pokeweed mitogen stimulation. IL-2 induced maximal Ig production in association with Staphylococcus aureus, whereas it inhibited pokeweed mitogen-induced production. In patients, levels of Ig production in response to mitogens and cytokines were reduced, particularly for the response to IL 2. The inhibitory effect of IL-4 on mitogen-induced Ig production was observed in RA patients as in the controls. Spontaneous production of IL-6 was increased in RA patients. These levels were correlated with indicators of active disease such as sedimentation rate and Ritchie index. IL-4 inhibited the production of IL-6, IL-1 beta, and tumor necrosis factor alpha (TNF alpha) by both controls and rheumatoid patients. Thus as first described for the T-cell response, mononuclear cells from RA patients display a reduced response to mitogens and cytokines which induce their B-cell differentiation into Ig-screening cells. However, IL-4 was able to inhibit Ig and cytokine production, properties suggesting a potential antiinflammatory role for this cytokine.
Assuntos
Artrite Reumatoide/imunologia , Citocinas/biossíntese , Imunoglobulinas/biossíntese , Leucócitos Mononucleares/metabolismo , Adolescente , Adulto , Idoso , Células Cultivadas , Feminino , Humanos , Imunoglobulina A/análise , Imunoglobulina M/análise , Imunofenotipagem , Técnicas In Vitro , Interleucina-1/biossíntese , Interleucina-2/farmacologia , Interleucina-4/farmacologia , Interleucina-6/biossíntese , Masculino , Pessoa de Meia-Idade , Mitógenos de Phytolacca americana/imunologia , Staphylococcus aureus/imunologia , Fator de Necrose Tumoral alfa/biossínteseRESUMO
OBJECTIVE: To assess the spontaneous production of proinflammatory cytokines and immunoglobulins in rheumatoid arthritis (RA) synovitis and modulation by interleukin-4 (IL-4). METHODS: We developed an ex vivo model of RA synovitis using pieces of RA synovium, and have studied the regulation of the production of IL-1 beta, IL-6, tumor necrosis factor alpha (TNF alpha), IgM, and IgG. RESULTS: Spontaneous production of proinflammatory cytokines in vitro was active, with prolonged cytokine gene transcription and translation. IL-6 was produced at higher levels than either IL-1 beta or TNF alpha, and explants produced more IgG than IgM. In contrast, IL-4 and interferon-gamma were undetectable. When pieces of synovium were incubated in the presence of IL-4, reduction of spontaneous proinflammatory cytokine and Ig production was observed. CONCLUSION: These results extend the observations of the antiinflammatory properties of IL-4 to an ex vivo situation, and provide the rationale for the clinical use of IL-4 in RA.
Assuntos
Artrite Reumatoide/metabolismo , Citocinas/metabolismo , Imunoglobulinas/metabolismo , Interleucina-4/farmacologia , Adulto , Idoso , Artrite Reumatoide/genética , Artrite Reumatoide/imunologia , Sequência de Bases , Citocinas/genética , Feminino , Humanos , Imunoglobulina G/genética , Imunoglobulina G/metabolismo , Imunoglobulina M/genética , Imunoglobulina M/metabolismo , Imunoglobulinas/genética , Interleucina-1/genética , Interleucina-1/metabolismo , Interleucina-6/genética , Interleucina-6/metabolismo , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Biossíntese de Proteínas , RNA Mensageiro/análise , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Membrana Sinovial/química , Membrana Sinovial/metabolismo , Transcrição Gênica , Fator de Necrose Tumoral alfa/genética , Fator de Necrose Tumoral alfa/metabolismoRESUMO
B lymphocytes activated by T cells in secondary lymphoid organs mature into plasma cells after migration into the medullary cords of these organs, mucosal lamina propria or bone marrow. To analyze each step leading to plasma cell generation, we set up a two-step culture system of purified tonsillar B cells. In a primary stage, B cell blasts were generated by co-culturing B cells with an irradiated T cell clone activated with immobilized anti-CD3. In a secondary step, culturing these blasts on bone marrow stromal cells (BMSC) induced them to secrete large amounts of IgG, as well as some IgM and IgA. Other fibroblast-like cell lines were less efficient at sustaining the differentiation of blasts into Ig-secreting cells, suggesting that these are specific properties of BMSC. Addition of IL-3 and IL-10 further stimulated IgG secretion by B cell blasts cultured on BMSC, mostly the IgG1 subclass. These two cytokines probably acted through different pathways, as (i) the effect of IL-3 but not IL-10 was dependent upon prolonged T cell pre-activation and (ii) their combined stimulatory effect was additive. B cell blasts cultured on BMSC with a combination of IL-3 and IL-10 differentiated into non-proliferating plasma cells as determined by poor thymidine incorporation, typical cellular morphology, intense expression of intracytoplasmic Igs, very high levels of surface CD38 and lack of surface CD20.
Assuntos
Linfócitos B/fisiologia , Células da Medula Óssea , Interleucina-10/fisiologia , Interleucina-3/fisiologia , Ativação Linfocitária , Plasmócitos/fisiologia , Linfócitos T/fisiologia , Adulto , Linfócitos B/imunologia , Linfócitos B/metabolismo , Diferenciação Celular/imunologia , Divisão Celular , Células Cultivadas , Humanos , Imunoglobulina G/biossíntese , Plasmócitos/imunologia , Células Estromais/citologiaRESUMO
The expression of the proinflammatory cytokine leukemia inhibitory factor (LIF) has been reported in the cartilage and synovium of rheumatoid arthritis (RA) patients. Here, we show that high levels of LIF were constitutively produced by cultures of synovium pieces. Low levels of LIF were produced spontaneously by isolated synoviocytes, but interleukin (IL)-1 beta caused a fourfold enhancement of this secretion. The anti-inflammatory cytokine IL-4 reduced the production of LIF by synovium pieces by 75%, as observed earlier with IL-6, IL-1 beta and tumor necrosis factor (TNF)-alpha. IL-4 had a direct effect since it inhibited LIF production by unstimulated and IL-1 beta- or TNF-alpha-stimulated synoviocytes. Conversely, IL-4 enhanced the production of IL-6, which shares with LIF biological activities and receptor components. The inhibitory effect of IL-4 was dose dependent and was reversed using a blocking anti-IL-4 receptor antibody. Similar inhibitory action of IL-4 on LIF production was observed on synovium pieces from patients with osteoarthritis and on normal synoviocytes. IL-10, another anti-inflammatory cytokine acting on monocytes, had no effect on LIF production by either synovium pieces or isolated synoviocytes. Thus, the production of LIF by synovium tissue was inhibited by IL-4 through both a direct effect on synoviocytes and an indirect effect by inhibition of the production of LIF-inducing cytokines.
Assuntos
Artrite Reumatoide/imunologia , Inibidores do Crescimento/biossíntese , Interleucina-10/farmacologia , Interleucina-4/farmacologia , Linfocinas/biossíntese , Membrana Sinovial/imunologia , Técnicas de Cultura , Humanos , Interleucina-1/farmacologia , Interleucina-6/metabolismo , Fator Inibidor de Leucemia , Receptores de Interleucina/fisiologia , Receptores de Interleucina-4 , Proteínas Recombinantes , Membrana Sinovial/metabolismoRESUMO
OBJECTIVE: To assess local bone resorption in the context of rheumatoid synovitis and its modulation by interleukin-4 (IL-4). METHODS: We developed an ex vivo model of bone resorption using juxtaarticular samples of bone obtained during joint surgery. We studied the histomorphometric parameters of bone resorption and the regulation of the production of IL-6, leukemia inhibitory factor (LIF), and the collagen cross-link pyridinoline, which is released during bone resorption in vivo. RESULTS: This was a sensitive and dynamic model of bone resorption. The bone samples produced high levels of pyridinoline and as much cytokine as synovium pieces obtained from the same joint. IL-4 induced a 70% reduction of IL-6 and LIF production by bone pieces and reduced pyridinoline levels. Histomorphometric studies performed on bone samples indicated a 35% increase in the mean total bone area after 7 days of treatment with IL-4. More importantly, with IL-4, osteoclasts were not detectable in the bone sections. CONCLUSION: The inhibitory effect of IL-4 on bone resorption extends our knowledge of its antiinflammatory properties and suggests that the inflammatory cytokine imbalance in rheumatoid synovium also contributes to defects in bone resorption in RA.
Assuntos
Artrite Reumatoide/fisiopatologia , Reabsorção Óssea/prevenção & controle , Interleucina-4/farmacologia , Osteoclastos/efeitos dos fármacos , Adulto , Idoso , Artrite Reumatoide/metabolismo , Osso e Ossos/metabolismo , Colágeno/metabolismo , Colágeno/farmacologia , Reagentes de Ligações Cruzadas/metabolismo , Citocinas/biossíntese , Feminino , Inibidores do Crescimento/metabolismo , Humanos , Interleucina-6/metabolismo , Articulações/metabolismo , Fator Inibidor de Leucemia , Linfocinas/metabolismo , Masculino , Pessoa de Meia-IdadeRESUMO
Functional expression of CD40 has recently been described on the surface of HUVEC, and activation of these cells with CD40 ligand (CD40-L) leads to increased adhesion molecule expression. Here, we analyzed the effect of CD40 triggering on cytokine production by HUVEC. CD40-L-transfected fibroblasts, in contrast to their untransfected counterparts, as well as a soluble recombinant human CD40-L/murine CD8alpha chimeric molecule were able to importantly increase (by a mean of fourfold) the production of leukemia inhibitory factor (LIF) by HUVEC. CD40-L displayed an additive effect with IL-4, IL-1alpha, and TNF-alpha on the enhancement of LIF secretion. Cyclosporin A did not affect LIF synthesis by resting or CD40-L-activated HUVEC, whereas dexamethasone diminished the basal level of LIF production and abrogated the CD40-L effect. The secretions of two other proinflammatory cytokines, granulocyte-macrophage CSF and IL-6, were also increased in the presence of CD40-L. However, CD40-L neither affected HUVEC proliferation nor rescued them from IFN-gamma- and TNF-alpha induced apoptosis. Together, these results indicate that endothelial cell activation by CD40-L may play an important role not only in leukocyte recruitment through enhancement of adhesion molecule expression, but also in the maintenance of an inflammatory loop through the increase in proinflammatory cytokine secretion.
Assuntos
Citocinas/metabolismo , Endotélio Vascular/metabolismo , Glicoproteínas de Membrana/farmacologia , Apoptose , Antígenos CD40 , Ligante de CD40 , Divisão Celular , Células Cultivadas , Ciclosporina/farmacologia , Dexametasona/farmacologia , Fator Estimulador de Colônias de Granulócitos e Macrófagos/metabolismo , Inibidores do Crescimento/metabolismo , Humanos , Interleucina-6/metabolismo , Fator Inibidor de Leucemia , Ligantes , Linfocinas/metabolismoRESUMO
The spontaneous production of IL-1 beta (IL-1 beta) and IL-1 receptor antagonist (IL-1Ra) by rheumatoid arthritis (RA) synovium, and the regulation of their production by IL-4 and IL-10, were studied. Supernatants from cultured synovium pieces from 19 RA patients were assayed for IL-1 beta and IL-1Ra production using ELISA and RIA, respectively. After 10 days of culture, spontaneous production of IL-1Ra was 1.42 +/- 0.43 ng/ml/100 mg of synovium whereas spontaneous production of IL-1 beta was 4.03 +/- 0.90 ng/ml/100 mg of synovium (n = 19). The addition of IL-4 reduced IL-1 beta production by 2.3-fold (p = 0.001) and increased that of IL-1Ra by 2.8-fold (p = 0.003). IL-10 had no significant effect on IL-1Ra production and suppressed IL-1 beta production (primarily in samples producing high levels of IL-1 beta). However, IL-10 was less potent than IL-4 in suppressing IL-1 beta production. IL-1Ra was mainly produced by rheumatoid synovial monocytes/macrophages. IL-4 was more potent than IL-10 in inducing IL-1Ra production by monocytes/macrophages purified from RA synovium, as well as from RA blood. Thus, RA synovium is characterized by an imbalance between IL-1Ra and IL-1 beta production, in favor of the latter. IL-4, and to a lesser extent IL-10, shift this balance in favor of an anti-inflammatory situation.
Assuntos
Artrite Reumatoide/imunologia , Citocinas/biossíntese , Membrana Sinovial/imunologia , Adulto , Idoso , Células Cultivadas , Técnicas de Cultura , Feminino , Humanos , Proteína Antagonista do Receptor de Interleucina 1 , Interleucina-1/biossíntese , Interleucina-10/fisiologia , Interleucina-4/fisiologia , Macrófagos/imunologia , Masculino , Pessoa de Meia-Idade , Monócitos/imunologia , Sialoglicoproteínas/biossíntese , Membrana Sinovial/citologiaRESUMO
Although T cell clone monospecificity is ensured by several allelic exclusion processes operating at either the genotypic or phenotypic levels, clones expressing two distinct alphabeta or gammadelta TCR have been described in several instances. Thus far, the origin of dual TCR-expressing cells and the homeostatic mechanisms controlling the size of this subset in the periphery remain poorly understood. In the course of a phenotypic analysis of gammadelta T cells in HIV-infected patients, we detected the presence of a T cell subset stained by both Vdelta2- and Vdelta3-specific mAb, which represented a large fraction (up to 16.5%) of gammadelta peripheral blood lymphocytes (PBL) in one HIV patient. The presence of two distinct functional delta chains on these cells was confirmed by phenotypic and molecular analysis of TCR transcripts expressed by Vdelta2+Vdelta3+ T cell clones derived from this patient. For 18 months, the absolute number of these cells varied similarly to the other PBL subsets, before becoming undetectable in blood samples. Moreover, most of these cells expressed CD8 receptors, which are classically found on activated, but not resting, gammadelta T cells. Taken together, these data suggest that dual TCR-expressing T cells are subjected to peripheral expansions and contractions presumably following antigen recognition, which would argue against a systematic counter-selection of these cells during peripheral antigen-driven responses.
Assuntos
Infecções por HIV/imunologia , Receptores de Antígenos de Linfócitos T gama-delta/imunologia , Subpopulações de Linfócitos T/imunologia , Anticorpos Monoclonais , Células Clonais/imunologia , Citometria de Fluxo , Rearranjo Gênico da Cadeia delta dos Receptores de Antígenos dos Linfócitos T , Rearranjo Gênico da Cadeia gama dos Receptores de Antígenos dos Linfócitos T , Humanos , Masculino , Fenótipo , Receptores de Antígenos de Linfócitos T gama-delta/genéticaRESUMO
A major feature of rheumatoid arthritis is an uncontrolled proliferation of synoviocytes. This is consistent with the active production of factors such as platelet-derived growth factor (PDGF) and IL-1 by the synovitis, which act in vivo as well as in vitro as potent synoviocyte growth factors. We have previously shown that IL-4 is able to inhibit growth factor production in an ex vivo model of synovitis. Herein, we show that IL-4 strongly inhibited PDGF and IL-1 beta stimulated rheumatoid arthritis synoviocyte proliferation in a dose-dependent manner and through its 130 kDa receptor. This antiproliferative effect of IL-4 directly correlated with a blockade of the synoviocyte cell cycle at the G0 + G1 phases. We also observed that IL-4 induced striking morphologic changes in IL-1 beta or PDGF-stimulated synoviocytes, including increased volume and granulosity. These changes led to major perturbations of the cell monolayer, associated with a marked decrease of synoviocyte viability. Taken together, these data indicate that IL-4 inhibits growth factor-induced proliferation of synoviocytes by interfering with the cell cycle, and by decreasing cell survival.
Assuntos
Artrite Reumatoide/patologia , Interleucina-1/antagonistas & inibidores , Interleucina-4/farmacologia , Fator de Crescimento Derivado de Plaquetas/antagonistas & inibidores , Membrana Sinovial/patologia , Ciclo Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Humanos , Receptores de Interleucina-4 , Receptores Mitogênicos/fisiologia , Membrana Sinovial/efeitos dos fármacosRESUMO
In normal persons, circulating gammadelta T cells comprise a minor cell subset (0.5%-6% of total lymphocytes). gammadelta T cells were studied in the context of therapeutic immunosuppression in transplanted patients. Flow cytometry detected an expansion of gammadelta T cells in 31 of 205 renal allograft recipients and in 2 of 41 uremic patients but in none of 45 healthy subjects. Univariate statistical analysis identified cytomegalovirus (CMV) infection (P<. 001), second graft (P<.001), and antithymocyte globulin treatment (P=.01) as three variables associated with high levels (>=6%) of circulating gammadelta T cells in allograft recipients. Multivariate analysis further indicated that CMV infection was the only independent parameter associated with >6% gammadelta T cells. gammadelta T cell expansion directly followed CMV infection and was never observed in persons who did not develop CMV infection. Thus gammadelta T cells may represent a first-line defense mechanism against CMV infection in a person whose alphabeta T cell response has been weakened by immunosuppression.
Assuntos
Infecções por Citomegalovirus/etiologia , Infecções por Citomegalovirus/imunologia , Transplante de Rim/efeitos adversos , Transplante de Rim/imunologia , Infecções Oportunistas/etiologia , Infecções Oportunistas/imunologia , Receptores de Antígenos de Linfócitos T gama-delta/metabolismo , Subpopulações de Linfócitos T/imunologia , Adolescente , Adulto , Idoso , Soro Antilinfocitário/efeitos adversos , Estudos de Casos e Controles , Infecções por Citomegalovirus/sangue , Feminino , Humanos , Hospedeiro Imunocomprometido , Contagem de Linfócitos , Masculino , Pessoa de Meia-Idade , Infecções Oportunistas/sangue , Estudos Prospectivos , Reoperação , Estudos Retrospectivos , Uremia/sangue , Uremia/imunologia , Uremia/cirurgiaRESUMO
CD40 ligand (CD40L)/CD40 interactions play a central role in T-cell-dependent B-cell activation as previously shown by in vitro studies, the phenotype of CD40L knockout mice and the defective expression of CD40L in patients who have X-linked immunodeficiency with hyper-IgM. The distribution of CD40 in cells other than of myeloid and lymphoid lineages has suggested additional functions for this receptor/ligand couple. Here we show that CD40L stimulates myelopoiesis with a noticeable effect on megakaryocytopoiesis in cocultures of hematopoietic progenitor cells and bone marrow stromal cells. These results suggest a mechanism by which T-cell or platelet-associated or soluble CD40L may regulate myelopoiesis. (Blood. 2000;95:3758-3764)